BSBR · NYSE · STOCK
Banco Santander (Brasil) (BSBR) Stock Analysis
$5.80
52W $4.94 – $7.32
56/100
$43.50B
29.4
0.18
Is BSBR Bullish or Bearish?
Mixed.
Innellis AI committee rates Banco Santander (Brasil) S.A. (BSBR) Watch with a composite score of 56/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +3.54 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -16.46 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Technical Analyst sees a compelling case — price structure making higher highs and higher lows. Risk Analyst remains cautious — high leverage (debt-to-equity 2.29) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- P/E of 7.9 is inexpensive for the broad market — Value
- Price-to-book of 1.0x is a discount to asset value — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- Debt-to-equity of 2.29 adds balance-sheet risk to the value case — Value
- 2 consecutive earnings misses -- execution concerns — Growth
- High leverage (debt-to-equity 2.29) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
56/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 70%
of 211 Financial Services peers
Value Analyst
bullish
65
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 7.9 is inexpensive for the broad market
− Debt-to-equity of 2.29 adds balance-sheet risk to the value case
Growth Analyst
neutral
52
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− 2 consecutive earnings misses -- execution concerns
Technical Analyst
bullish
69
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Risk Analyst
bearish
30
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 2.29) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 56.5 to 56.5.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
Analyst-level changes:
- Value Analyst: +1 bullish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
53.3
Neutral
MACD Histogram
0.015
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Support
$5.70
Resistance
$6.04
Bollinger %B
0.56
Inside Bands
Price vs Moving Averages
EMA 9
$5.77
Above
EMA 21
$5.76
Above
EMA 50
$5.72
Above
EMA 200
$5.70
Above
Fundamental Analysis
Valuation
80
Growth
10
Profitability
39
Financial Health
33
Cash Flow
70
Valuation
P/E Ratio
29.4×
P/B Ratio
1.69×
PEG Ratio
-0.77
Dividend Yield
8.00%
52W High
$7.32
52W Low
$4.94
Quality & Growth
ROE
1019.9%
ROA
100.5%
Gross Margin
3757.0%
Operating Margin
1954.9%
Revenue Growth YoY
—
Debt / Equity
1.17
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 29.4 (moderate relative to a 15-40x range); Price-to-book of 1.7x; PEG ratio of -0.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 10.2%; Return on assets of 1.0%; Net margin of 9.9%; Gross margin of 37.6%; Current ratio of 0.34 (tight short-term liquidity); Debt-to-equity of 1.17; Free cash flow per share is positive (4.42); Most recent quarter missed estimates by 64.7%; 2 consecutive earnings misses
Get the Full BSBR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →